Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00012610
Status:
COMPLETED
Last Update Posted:
2015-04-07
First Post:
2001-03-14
Brief Title:
Efficacy of Telepsychiatry in the Treatment of Depression
Sponsor:
US Department of Veterans Affairs
Organization:
VA Office of Research and Development
Study Overview
Official Title:
Efficacy of Telepsychiatry in the Treatment of Depression
Status:
COMPLETED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Telepsychiatry is a novel means of providing expert psychiatric treatment to patients who live far from a source of care If it can be demonstrated that treatment via telepsychiatry is as effective as in-person treatment then many individuals with psychiatric illness will have easy access to psychiatric care even if they live in geographically remote areas
Detailed Description:
Background
Telepsychiatry is a novel means of providing expert psychiatric treatment to patients who live far from a source of care If it can be demonstrated that treatment via telepsychiatry is as effective as in-person treatment then many individuals with psychiatric illness will have easy access to psychiatric care even if they live in geographically remote areas
Objectives
The major goal of this study was to determine whether treatment of depressive disorders via telepsychiatry is as effective as in-person treatment In addition this study was designed to determine if depressed patients are as compliant and as satisfied with telepsychiatry as with in-person treatment Another goal was to compare the cost and cost-effectiveness of remote treatment via telepsychiatry to in-person treatment
Methods
In this randomized controlled trial veterans who presented with depression to any of three VA Maryland Health Care facilities with a SCID-IV depression diagnosis and a Hamilton Rating Scale for Depression Ham-D score of 16 or above were eligible for participation Eligible veterans were randomized to either in-person treatment or remote treatment Treatment occurred over six months and consisted of psychotropic medication and psycho-education concerning the disease medications and side effects The major outcome variables included changes in Ham-D depression ratings and Beck Depression Inventory BDI self-reported depression ratings
Status
Completed
Telepsychiatry is a novel means of providing expert psychiatric treatment to patients who live far from a source of care If it can be demonstrated that treatment via telepsychiatry is as effective as in-person treatment then many individuals with psychiatric illness will have easy access to psychiatric care even if they live in geographically remote areas
Objectives
The major goal of this study was to determine whether treatment of depressive disorders via telepsychiatry is as effective as in-person treatment In addition this study was designed to determine if depressed patients are as compliant and as satisfied with telepsychiatry as with in-person treatment Another goal was to compare the cost and cost-effectiveness of remote treatment via telepsychiatry to in-person treatment
Methods
In this randomized controlled trial veterans who presented with depression to any of three VA Maryland Health Care facilities with a SCID-IV depression diagnosis and a Hamilton Rating Scale for Depression Ham-D score of 16 or above were eligible for participation Eligible veterans were randomized to either in-person treatment or remote treatment Treatment occurred over six months and consisted of psychotropic medication and psycho-education concerning the disease medications and side effects The major outcome variables included changes in Ham-D depression ratings and Beck Depression Inventory BDI self-reported depression ratings
Status
Completed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None